GTR Home > Tests > SDHD-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome


Test order codeHelp: SDHD

Test name


SDHD-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome (SDHD)

Purpose of the test


This is a clinical test intended for Help: Mutation Confirmation, Pre-symptomatic, Diagnosis



1 condition tested. Click Indication tab for more information.


Molecular Genetics
ESequence analysis of select exons
Next-Generation (NGS)/Massively parallel sequencing (MPS)
  • Illumina HiSeq™2000 system
CSequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
  • Illumina HiSeq™2000 system

Summary of what is tested

1 genes and variants. Click Methodology tab for more information.


Clinical validity


Not provided

Clinical utility


Not provided

How to order


Refer to list of tests and instructions on website
Order URL Help:

Practice guidelines

  • ES, 2014
    Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
  • ASCO, 2014
    American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.
  • KCRNC, 2013
    Canadian guideline on genetic screening for hereditary renal cell cancers.
  • NANETS, 2010
    The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma & Medullary Thyroid Cancer

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center